 Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:  The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated savings and operational benefits from the asset realignment;  Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;  Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;  An inability to raise or sustain prices for products or services;  An inability to maintain appropriate relations with unions and employees;  The inability to achieve expected results from our acquisition activities;  Our ability to continue to pay cash dividends;  The amount and timing of repurchases of our common shares, if any; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.  The above list of factors is not exhaustive.  We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise.  PolyOne’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of the Company and each business segment and to allocate resources. S&P 500 PolyOne Corporation Page 9 2006 YTD 2015 2020 “Where we were” “Where we are” Platinum Vision 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 17.2% 20%+ Global Specialty Engineered Materials 1.1% 15.3% 20%+ Designed Structures & Solutions 1.4% (2012) 3.3% 12 – 14% Performance Products & Solutions 5.5% 7.6% 10 – 12% Distribution 2.6% 6.5% 6.5 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 67% 80%+ 3) ROIC (after-tax)* 5.0% 11.7% 15% 4) Adjusted EPS Growth N/A 23 Consecutive Quarters of YOY EPS Growth Double Digit Expansion Proof of Performance & 2020 Goals *ROIC is defined as TTM adjusted operating income after-tax divided by the sum of average debt and equity over a 5 quarter period PolyOne Corporation Page 10 Platinum Vision: Pathway to Accelerated Growth Organic Sales Growth Margin Expansion Share Repurchases Acquisitions PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2014 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 27% 2006 2014 Specialty Platform Gross Margin % 20% 44% 2006 2014 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 12 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 13 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 6 9 7 3 5 12 5 3 2 8 4 2 4 3 1 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 14 8 18 12 22 74 Addressable Market ($ millions) $700 $600 $600 $1,900 PolyOne Corporation Page 14 60% 102% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 Q2 2015 Pension Funding** As of June 30, 2015 Debt Maturities & Pension Funding Net Debt / Adjusted EBITDA** = 2.0x Coupon Rate: 7.500% Variable* 7.375% 5.250% ** includes US-qualified pension plans only *Weighted average rate on revolver was 2.40% as of 6/30/15 **TTM 6/30/2015 $49 $79 $317 $600 $400 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2018 2020 2023 Debt Maturities As of June 30, 2015 ($ millions) PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return  Expanding our sales, marketing, and technical capabilities  Investing in operational and LSS initiatives  ~75% of capital expenditures fund growth initiatives Organic Growth Acquisitions Share Repurchases Dividends $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend  Targets that expand our: • Specialty offerings • End market presence • Geographic breadth  Synergy opportunities  Adjacent material solutions  Repurchased nearly 600K shares in Q2 2015  Repurchased 12.4 million shares since early 2013  7.6 million shares are available for repurchase under the current authorization PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

Avient Corporation ประกาศความเป็นส่วนตวัสําหรบัผูส้มคัรงาน เรายนิดทีีคุ่ณสนใจในการทํางานกบั Avient Avient Corporation และบรษิทัในเครอื (เรยีกรวมกนัว่า “Avient” “เรา” “พวกเรา” หรอื “ของเรา”) มุ่งมั่นทีจ่ะปกป้องความเป็นส่วนตวัและขอ้มูลส่วนบุคคลทีร่วบรวมจากผูส้มคัรงานผ่านขัน้ตอนการสมคัรงานทางออนไลนแ์ละชอ่งท างอืน่ ๆ ประกาศความเป็นส่วนตวัสําหรบัผูส้มคัรงานนี ้(“ประกาศ”) ระบุวธิทีี ่Avient รวบรวม ใช ้ หรอืเปิดเผยขอ้มูลส่วนบุคคลจากผูส้มคัรงานและผูส้มคัร (เรยีกรวมกนัว่า “คุณ”) เมือ่คุณเขา้ถงึหรอืใชเ้ว็บไซตห์างานของเรา รวมถงึ https://avient.referrals.selectminds.com/ (“เว็บไซต”์) ประกาศฉบบันีไ้ม่ครอบคลุมถงึการใชบ้รกิารของ Avient ในฐานะผูบ้รโิภคหรอืการใชเ้ว็บไซตแ์ละแอปพลเิคชนัของบุคคลทีส่ามใด ๆ ทีคุ่ณอาจม ี รวมถงึเว็บไซตใ์ดทีเ่ช ือ่มโยงไปยงัเว็บไซตข์องเรา สําหรบัขอ้มูลเพิม่เตมิเกีย่วกบัวธิทีี ่Avient ประมวลผลขอ้มูลส่วนบุคคลของคุณสําหรบับรกิารเหล่านีแ้ละเว็บไซตข์องบุคคลทีส่าม โปรดเยีย่มชมคําแถลงความเป็นส่วนตวัของ Avient Corporation ซึง่มอียู่ที ่https://www.avient.com/company/policies-and-governance/avient- corporation-privacy-statement) กอ่นทีคุ่ณจะดําเนินการสมคัรต่อไป เราตอ้งการทีจ่ะแจง้ใหคุ้ณทราบสัน้ ๆ เกีย่วกบัวธิกีารทีเ่ราประมวลผลและปกป้องขอ้มูลส่วนบุคคลของคุณ โปรดอ่านประกาศฉบบันีอ้ย่างละเอยีดถีถ่ว้น โดยการส่งใบสมคัร เรซเูม่และ/หรอื CV ของคุณโดยใชเ้ครือ่งมอืการสมคัรออนไลนข์องเรา ขอ้มูลส่วนบุคคลของคุณจะไดร้บัการจดัการและปกป้องตามประกาศฉบบันี ้ เมือ่คุณไดส้่งใบสมคัรของคุณแลว้ คุณอาจจะเพิม่ขอ้มูลของคุณไปยงัคลงัผูส้มคัรทัว่โลกของเราได ้การทําเชน่นีจ้ะชว่ยให ้Avient สามารถแจง้ใหคุ้ณทราบถงึตําแหน่งทีน่่าสนใจอืน่ ๆ ทีคุ่ณอาจมคีุณสมบตัเิหมาะสม หากคุณมคีําถามใด ๆ เกีย่วกบัขอ้มูลส่วนบุคคลของคุณหรอืตอ้งการตดิต่อเราดว้ยเหตุผลอืน่ใด โปรดใชข้อ้มูลการตดิต่อทีใ่หไ้วด้า้นล่าง หน่วยงาน Avient ในพืน้ทีข่องเขตอํานาจศาลทีคุ่ณสมคัรงานจะทําหนา้ทีเ่ป็นผูค้วบคุมขอ้มูลเกีย่วกบัขอ้มูลส่วนบุคคลของคุณ 1.

Individual/sole proprietor or single-member LLC C Corporation S Corporation Partnership Trust/estate Limited liability company.

© 2024, All Rights Reserved Avient Corporation https://www.avient.com/company/policies-and-governance-0/global-iso-certificate-library

Silicone is a breathable material that is beneficial for applications such as wound covering and contact lenses. Contact us at +1.844.4AVIENT (1.844.428.4368) or visit avient.com to find out more.

Neem onder deze omstandigheden onmiddellijk contact op met de bedrijfsfunctionaris inzake ethiek (ethics officer@avient.com) of de juridische afdeling (legal officer@avient.com). Neem contact op met uw juridische partner om een due diligence-beoordeling aan te vragen en zorg ervoor dat u schriftelijke goedkeuring hebt ontvangen voordat u met een vertegenwoordiger of derde partij werkt.

Seller may, during any period of shortage due to force majeure event, prorate, and allocate its supply of such materials among itself for its own consumption, its subsidiaries, affiliated companies, its accepted orders, contract customers, and its regular customers not then under contract in such a manner as may be deemed fair and reasonable by Seller. In such cases, regarding existing sales of Product, Seller may distribute Product among itself for its own uses, its subsidiaries, affiliated companies, its accepted orders, contract customers, and its regular customers not then under contract, in such manner as Seller deems fair and practicable.

Prioritize company-level growth vectors meeting the four-point criteria MARKETS TECHNOLOGY CUSTOMER SCALE 3. All Rights Reserved 2025 11 Pathway to 20%+ adjusted EBITDA margins 1 Operating leverage • Organic volume growth and SG&A efficiencies from prioritizing resources across the company 2 Mix improvement • Increased sales in higher margin growth platforms 3 Productivity • Manufacturing & sourcing efficiencies • Footprint optimization • Digital technologies Avient margin expansion Schematic illustration only Productivity +400bps margin expansion 20%+ Strategic objective 16.2% 2024 adjusted EBITDA margin +2% +1% Operating leverage +1% Mix improvement Copyright © .

Ensuring regulatory compliance for products such as food contact, toys or medical applications can be a complex and time consuming process.

Ensuring regulatory compliance for products such as food contact, toys or medical applications can be a complex and time consuming process.